Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1990 Dec;45(12):957–961. doi: 10.1136/thx.45.12.957

Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

C R Hind 1
PMCID: PMC462846  PMID: 2281430

Full text

PDF
957

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammann A. J., Schiffman G., Abrams D., Volberding P., Ziegler J., Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA. 1984 Mar 16;251(11):1447–1449. [PubMed] [Google Scholar]
  2. Beckhardt R. N., Farady N., May M., Torres R. A., Strauchen J. A. Increased incidence of malignant lymphoma in AIDS: a comparison of risk groups and possible etiologic factors. Mt Sinai J Med. 1988 Oct;55(5):383–389. [PubMed] [Google Scholar]
  3. Ben-Haim S. A., Ben-Ami H., Edoute Y., Goldstien N., Barzilai D. Talcosis presenting as pulmonary infiltrates in an HIV-positive heroin addict. Chest. 1988 Sep;94(3):656–658. doi: 10.1378/chest.94.3.656. [DOI] [PubMed] [Google Scholar]
  4. Brettle R. P., Bisset K., Burns S., Davidson J., Davidson S. J., Gray J. M., Inglis J. M., Lees J. S., Mok J. Human immunodeficiency virus and drug misuse: the Edinburgh experience. Br Med J (Clin Res Ed) 1987 Aug 15;295(6595):421–424. doi: 10.1136/bmj.295.6595.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Briggs J. H., McKerron C. G., Souhami R. L., Taylor D. J., Andrews H. Severe systemic infections complicating "mainline" heroin addiction. Lancet. 1967 Dec 9;2(7528):1227–1231. doi: 10.1016/s0140-6736(67)90565-x. [DOI] [PubMed] [Google Scholar]
  6. Brown D. G., Aguirre A., Weaver A. 67Gallium scanning in talc-induced pulmonary granulomatosis. Chest. 1980 Apr;77(4):561–565. doi: 10.1378/chest.77.4.561. [DOI] [PubMed] [Google Scholar]
  7. Brown S. M., Stimmel B., Taub R. N., Kochwa S., Rosenfield R. E. Immunologic dysfunction in heroin addicts. Arch Intern Med. 1974 Dec;134(6):1001–1006. [PubMed] [Google Scholar]
  8. Camargo G., Colp C. Pulmonary function studies in ex-heroin users. Chest. 1975 Mar;67(3):331–334. doi: 10.1378/chest.67.3.331. [DOI] [PubMed] [Google Scholar]
  9. Catterall J. R., Hofflin J. M., Remington J. S. Pulmonary toxoplasmosis. Am Rev Respir Dis. 1986 Apr;133(4):704–705. doi: 10.1164/arrd.1986.133.4.704. [DOI] [PubMed] [Google Scholar]
  10. Chaisson R. E., Bacchetti P., Osmond D., Brodie B., Sande M. A., Moss A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989 Jan 27;261(4):561–565. [PubMed] [Google Scholar]
  11. Chaisson R. E. Bacterial pneumonia in patients with human immunodeficiency virus infection. Semin Respir Infect. 1989 Jun;4(2):133–138. [PubMed] [Google Scholar]
  12. Chaisson R. E., Schecter G. F., Theuer C. P., Rutherford G. W., Echenberg D. F., Hopewell P. C. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis. 1987 Sep;136(3):570–574. doi: 10.1164/ajrccm/136.3.570. [DOI] [PubMed] [Google Scholar]
  13. Chambers H. F., Korzeniowski O. M., Sande M. A. Staphylococcus aureus endocarditis: clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) 1983 May;62(3):170–177. [PubMed] [Google Scholar]
  14. Cherubin C. E. The medical sequelae of narcotic addiction. Ann Intern Med. 1967 Jul;67(1):23–33. doi: 10.7326/0003-4819-67-1-23. [DOI] [PubMed] [Google Scholar]
  15. Collignon P. J., Sorrell T. C. Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):861–862. doi: 10.1136/bmj.287.6396.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cooper E. B. Melioidosis. JAMA. 1967 May 8;200(6):452–453. [PubMed] [Google Scholar]
  17. Des Jarlais D. C., Stoneburner R., Thomas P., Friedman S. R. Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City. Lancet. 1987 Oct 31;2(8566):1024–1025. doi: 10.1016/s0140-6736(87)92586-4. [DOI] [PubMed] [Google Scholar]
  18. Dworkin R. J., Lee B. L., Sande M. A., Chambers H. F. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet. 1989 Nov 4;2(8671):1071–1073. doi: 10.1016/s0140-6736(89)91083-0. [DOI] [PubMed] [Google Scholar]
  19. Glassroth J., Adams G. D., Schnoll S. The impact of substance abuse on the respiratory system. Chest. 1987 Apr;91(4):596–602. doi: 10.1378/chest.91.4.596. [DOI] [PubMed] [Google Scholar]
  20. Glatt A. E., Chirgwin K. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med. 1990 Feb;150(2):271–279. [PubMed] [Google Scholar]
  21. Gottlieb L. S., Boylen T. C. Pulmonary complications of drug abuse. West J Med. 1974 Jan;120(1):8–16. [PMC free article] [PubMed] [Google Scholar]
  22. Greene J. B., Sidhu G. S., Lewin S., Levine J. F., Masur H., Simberkoff M. S., Nicholas P., Good R. C., Zolla-Pazner S. B., Pollock A. A. Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med. 1982 Oct;97(4):539–546. doi: 10.7326/0003-4819-97-4-539. [DOI] [PubMed] [Google Scholar]
  23. Gumbs R. V., McCauley D. I. Hilar and mediastinal adenopathy in septic pulmonary embolic disease. Radiology. 1982 Feb;142(2):313–315. doi: 10.1148/radiology.142.2.7054820. [DOI] [PubMed] [Google Scholar]
  24. Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989 May 12;261(18):2677–2684. [PubMed] [Google Scholar]
  25. Harries A. D. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 1990 Feb 17;335(8686):387–390. doi: 10.1016/0140-6736(90)90216-r. [DOI] [PubMed] [Google Scholar]
  26. Hoover E. L., Hsu H. K., Webb H., Toporoff B., Minnard E., Cunningham J. N. The surgical management of empyema thoracis in substance abuse patients: a 5-year experience. Ann Thorac Surg. 1988 Nov;46(5):563–566. doi: 10.1016/s0003-4975(10)64698-x. [DOI] [PubMed] [Google Scholar]
  27. Hopewell P. C. Prevention of lung infections associated with human immunodeficiency virus infection. Thorax. 1989 Dec;44(12):1038–1044. doi: 10.1136/thx.44.12.1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Huang K. L., Ruben F. L., Rinaldo C. R., Jr, Kingsley L., Lyter D. W., Ho M. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA. 1987 Apr 17;257(15):2047–2050. [PubMed] [Google Scholar]
  29. Kaplan L. D., Abrams D. I., Feigal E., McGrath M., Kahn J., Neville P., Ziegler J., Volberding P. A. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA. 1989 Feb 3;261(5):719–724. [PubMed] [Google Scholar]
  30. Kaufman R. E., Johnson R. E., Jaffe H. W., Thornsberry C., Reynolds G. H., Wiesner P. J. National gonorrhea therapy monitoring study: treatment results. N Engl J Med. 1976 Jan 1;294(1):1–4. doi: 10.1056/NEJM197601012940101. [DOI] [PubMed] [Google Scholar]
  31. Koplan J. P., Hardy A. M., Allen J. R. Epidemiology of the acquired immunodeficiency syndrome in intravenous drug abusers. Adv Alcohol Subst Abuse. 1985 Fall;5(1-2):13–23. doi: 10.1300/J251v05n01_02. [DOI] [PubMed] [Google Scholar]
  32. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  33. Lazzarin A., Uberti-Foppa C., Galli M., Crocchiolo P., Moroni M. Pulmonary candidiasis in a heroin addict: some remarks on its aetiology and pathogenesis. Br J Addict. 1985 Mar;80(1):103–104. doi: 10.1111/j.1360-0443.1985.tb05296.x. [DOI] [PubMed] [Google Scholar]
  34. Levy N., Carlson J. R., Hinrichs S., Lerche N., Schenker M., Gardner M. B. The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl J Med. 1986 Feb 13;314(7):446–446. doi: 10.1056/NEJM198602133140711. [DOI] [PubMed] [Google Scholar]
  35. Louria D. B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967 Jul;67(1):1–22. doi: 10.7326/0003-4819-67-1-1. [DOI] [PubMed] [Google Scholar]
  36. Marantz P. R., Linzer M., Feiner C. J., Feinstein S. A., Kozin A. M., Friedland G. H. Inability to predict diagnosis in febrile intravenous drug abusers. Ann Intern Med. 1987 Jun;106(6):823–828. doi: 10.7326/0003-4819-106-6-823. [DOI] [PubMed] [Google Scholar]
  37. Millar A. B., Mitchell D. M. AIDS and the lung. 4-- Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus. Thorax. 1990 Jan;45(1):57–61. doi: 10.1136/thx.45.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Miller R. F., Leigh T. R., Collins J. V., Mitchell D. M. AIDS and the lung. 5--Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus. Thorax. 1990 Jan;45(1):62–65. doi: 10.1136/thx.45.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Miller R. F., Mitchell D. M. Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia. Thorax. 1990 Feb;45(2):140–146. doi: 10.1136/thx.45.2.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mitchell D. M., Johnson M. A. AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome. Thorax. 1990 Mar;45(3):219–224. doi: 10.1136/thx.45.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Murray J. F., Felton C. P., Garay S. M., Gottlieb M. S., Hopewell P. C., Stover D. E., Teirstein A. S. Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med. 1984 Jun 21;310(25):1682–1688. doi: 10.1056/NEJM198406213102529. [DOI] [PubMed] [Google Scholar]
  42. Murray J. F., Garay S. M., Hopewell P. C., Mills J., Snider G. L., Stover D. E. NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis. 1987 Feb;135(2):504–509. doi: 10.1164/arrd.1987.135.2.504. [DOI] [PubMed] [Google Scholar]
  43. Murray J. F., Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis. 1990 May;141(5 Pt 1):1356–1372. doi: 10.1164/ajrccm/141.5_Pt_1.1356. [DOI] [PubMed] [Google Scholar]
  44. Murray J. F. The white plague: down and out, or up and coming? J. Burns Amberson lecture. Am Rev Respir Dis. 1989 Dec;140(6):1788–1795. doi: 10.1164/ajrccm/140.6.1788. [DOI] [PubMed] [Google Scholar]
  45. Navarro C., Dickinson P. C., Kondlapoodi P., Hagstrom J. W. Mycotic aneurysms of the pulmonary arteries in intravenous drug addicts. Report of three cases and review of the literature. Am J Med. 1984 Jun;76(6):1124–1131. doi: 10.1016/0002-9343(84)90869-6. [DOI] [PubMed] [Google Scholar]
  46. Neild J. E., Eykyn S. J., Phillips I. Lung abscess and empyema. Q J Med. 1985 Dec;57(224):875–882. [PubMed] [Google Scholar]
  47. Nicolosi A., Lazzarin A. HIV seroconversion rates in intravenous drug abusers from northern Italy. Lancet. 1989 Jul 29;2(8657):269–269. doi: 10.1016/s0140-6736(89)90448-0. [DOI] [PubMed] [Google Scholar]
  48. Niedt G. W., Schinella R. A. Acquired immunodeficiency syndrome. Clinicopathologic study of 56 autopsies. Arch Pathol Lab Med. 1985 Aug;109(8):727–734. [PubMed] [Google Scholar]
  49. O'Connor R. N., Brunham R. C., Bowden D. H. Pulmonary talc granulomatosis mimicking Pneumocystis carinii pneumonia. CMAJ. 1988 Jan 1;138(1):53–54. [PMC free article] [PubMed] [Google Scholar]
  50. O'Donnell A. E., Pappas L. S. Pulmonary complications of intravenous drug abuse. Experience at an inner-city hospital. Chest. 1988 Aug;94(2):251–253. doi: 10.1378/chest.94.2.251. [DOI] [PubMed] [Google Scholar]
  51. Overland E. S., Nolan A. J., Hopewell P. C. Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities. Am J Med. 1980 Feb;68(2):231–237. doi: 10.1016/0002-9343(80)90359-9. [DOI] [PubMed] [Google Scholar]
  52. Pelletier L. L., Jr, Petersdorf R. G. Infective endocarditis: a review of 125 cases from the University of Washington Hospitals, 1963-72. Medicine (Baltimore) 1977 Jul;56(4):287–313. [PubMed] [Google Scholar]
  53. Pitchenik A. E., Cole C., Russell B. W., Fischl M. A., Spira T. J., Snider D. E., Jr Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med. 1984 Nov;101(5):641–645. doi: 10.7326/0003-4819-101-5-641. [DOI] [PubMed] [Google Scholar]
  54. Pitchenik A. E., Rubinson H. A. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis. 1985 Mar;131(3):393–396. doi: 10.1164/arrd.1985.131.3.393. [DOI] [PubMed] [Google Scholar]
  55. Polsky B., Gold J. W., Whimbey E., Dryjanski J., Brown A. E., Schiffman G., Armstrong D. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Jan;104(1):38–41. doi: 10.7326/0003-4819-104-1-38. [DOI] [PubMed] [Google Scholar]
  56. Quinn T. C., Zacarias F. R., St John R. K. HIV and HTLV-I infections in the Americas: a regional perspective. Medicine (Baltimore) 1989 Jul;68(4):189–209. doi: 10.1097/00005792-198907000-00001. [DOI] [PubMed] [Google Scholar]
  57. Reichman L. B., Felton C. P., Edsall J. R. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979 Mar;139(3):337–339. [PubMed] [Google Scholar]
  58. Rosenbaum R. B., Barber J. V., Stevens D. A. Candida albicans pneumonia. Diagnosis by pulmonary aspiration, recovery without treatment. Am Rev Respir Dis. 1974 Mar;109(3):373–378. doi: 10.1164/arrd.1974.109.3.373. [DOI] [PubMed] [Google Scholar]
  59. Schoenbaum E. E., Hartel D., Selwyn P. A., Klein R. S., Davenny K., Rogers M., Feiner C., Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989 Sep 28;321(13):874–879. doi: 10.1056/NEJM198909283211306. [DOI] [PubMed] [Google Scholar]
  60. Selwyn P. A., Feingold A. R., Hartel D., Schoenbaum E. E., Alderman M. H., Klein R. S., Friedland G. H. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS. 1988 Aug;2(4):267–272. doi: 10.1097/00002030-198808000-00005. [DOI] [PubMed] [Google Scholar]
  61. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
  62. Simberkoff M. S., El Sadr W., Schiffman G., Rahal J. J., Jr Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis. 1984 Dec;130(6):1174–1176. doi: 10.1164/arrd.1984.130.6.1174. [DOI] [PubMed] [Google Scholar]
  63. Smith W. R., Wells I. D., Glauser F. L., Novey H. S. High incidence of precipitins in sera of heroin addicts. JAMA. 1975 Jun 30;232(13):1337–1338. [PubMed] [Google Scholar]
  64. Snider G. L. More on pulmonary research: topics, costs another view. Am Rev Respir Dis. 1987 Jul;136(1):5–6. doi: 10.1164/ajrccm/136.1.5-a. [DOI] [PubMed] [Google Scholar]
  65. Spira T. J., Des Jarlais D. C., Marmor M., Yancovitz S., Friedman S., Garber J., Cohen H., Cabradilla C., Kalyanaraman V. C. Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N Engl J Med. 1984 Aug 16;311(7):467–468. doi: 10.1056/NEJM198408163110712. [DOI] [PubMed] [Google Scholar]
  66. Stern W. Z., Subbarao K. Pulmonary complications of drug addiction. Semin Roentgenol. 1983 Jul;18(3):183–197. doi: 10.1016/0037-198x(83)90022-6. [DOI] [PubMed] [Google Scholar]
  67. Stover D. E., White D. A., Romano P. A., Gellene R. A., Robeson W. A. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):429–437. doi: 10.1016/0002-9343(85)90334-1. [DOI] [PubMed] [Google Scholar]
  68. Suffredini A. F., Ognibene F. P., Lack E. E., Simmons J. T., Brenner M., Gill V. J., Lane H. C., Fauci A. S., Parrillo J. E., Masur H. Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Jul;107(1):7–13. doi: 10.7326/0003-4819-107-1-7. [DOI] [PubMed] [Google Scholar]
  69. Sunderam G., McDonald R. J., Maniatis T., Oleske J., Kapila R., Reichman L. B. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA. 1986 Jul 18;256(3):362–366. [PubMed] [Google Scholar]
  70. Tuazon C. U., Cardella T. A., Sheagren J. N. Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med. 1975 Dec;135(12):1555–1561. [PubMed] [Google Scholar]
  71. Wagner B. M. New frontiers in neonatal neuropathology. Hum Pathol. 1987 Jan;18(1):1–2. doi: 10.1016/s0046-8177(87)80185-5. [DOI] [PubMed] [Google Scholar]
  72. White D. A., Matthay R. A. Noninfectious pulmonary complications of infection with the human immunodeficiency virus. Am Rev Respir Dis. 1989 Dec;140(6):1763–1787. doi: 10.1164/ajrccm/140.6.1763. [DOI] [PubMed] [Google Scholar]
  73. Winter S. M., Bernard E. M., Gold J. W., Armstrong D. Humoral response to disseminated infection by Mycobacterium avium-Mycobacterium intracellulare in acquired immunodeficiency syndrome and hairy cell leukemia. J Infect Dis. 1985 Mar;151(3):523–527. doi: 10.1093/infdis/151.3.523. [DOI] [PubMed] [Google Scholar]
  74. Witt D. J., Craven D. E., McCabe W. R. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med. 1987 May;82(5):900–906. doi: 10.1016/0002-9343(87)90150-1. [DOI] [PubMed] [Google Scholar]
  75. Wood C. C., McNamara J. G., Schwarz D. F., Merrill W. W., Shapiro E. D. Prevention of pneumococcal bacteremia in a child with acquired immunodeficiency syndrome-related complex. Pediatr Infect Dis J. 1987 Jun;6(6):564–566. doi: 10.1097/00006454-198706000-00015. [DOI] [PubMed] [Google Scholar]
  76. Woodhead M. A., Macfarlane J. T., McCracken J. S., Rose D. H., Finch R. G. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987 Mar 21;1(8534):671–674. doi: 10.1016/s0140-6736(87)90430-2. [DOI] [PubMed] [Google Scholar]
  77. Zagury D., Bernard J., Leonard R., Cheynier R., Feldman M., Sarin P. S., Gallo R. C. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 1986 Feb 21;231(4740):850–853. doi: 10.1126/science.2418502. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES